Pharmaceutical patent settlements: the antitrust risks.
Balto
D A
DA
Office of Policy and Evaluation, Bureau of Competition, FTC, USA.
D016363:Antitrust Laws; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics; D004465:Economic Competition / Q000331:legislation & jurisprudence; D017850:Economics, Pharmaceutical; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States; D014485:United States Federal Trade Commission; D014486:United States Food and Drug Administration
D016568:Drugs, Generic